• OpenAI launched the Rosalind Biodefense program to sponsor trusted developers building biodefense and pandemic-preparedness applications using GPT-Rosalind.
• Move positions OpenAI to deepen ties with public-sector and mission-driven life-sciences buyers, building a defensible channel for high-stakes deployments.
• Trusted-access expansion for select US government and allied partners aims to embed GPT-Rosalind in early warning, outbreak planning, diagnostics, countermeasure development.
• Program reinforces OpenAI’s competitive advantage in regulated, dual-use domains by pairing frontier capability with controlled distribution and safety governance.
• Initial participants include Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory, CEPI, signaling credibility for broader institutional adoption.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OpenAI Inc. published the original content used to generate this news brief on May 29, 2026, and is solely responsible for the information contained therein.